论文部分内容阅读
Background: To investigate the role of Icariside Ⅱ (ICA Ⅱ) on endothelial nitric oxide synthase (eNOS) expression regulated by miR-155,the human cavernous endothelial cells (HCECs) were exposed to a diabetic-like environment and treated with ICA Ⅱ.